10x Genomics
328 hedge funds and large institutions have $11.5B invested in 10x Genomics in 2021 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 115 increasing their positions, 105 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
14% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 51
25% less capital invested
Capital invested by funds: $15.2B → $11.5B (-$3.76B)
57% less call options, than puts
Call options by funds: $32.4M | Put options by funds: $75.8M
Holders
328
Holding in Top 10
8
Calls
$32.4M
Puts
$75.8M
Top Buyers
| 1 | +$254M | |
| 2 | +$117M | |
| 3 | +$76.4M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$74.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$68.1M |
Top Sellers
| 1 | -$174M | |
| 2 | -$95.6M | |
| 3 | -$65.4M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$53M |
| 5 |
Goldman Sachs
New York
|
-$46.2M |